20
Aurobindo Pharma Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Lisinopril dihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2003-211 - Rev 04
This Chemical Type CEP, issued on December 13, 2017, remains in force until November 25, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 1120 associated with this CEP further emphasizes